Argenx
ARGX
$1,008
Share price
0.99%
Change (1 day)
59.60%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Market capitalization of Argenx (ARGX)
Market cap: NZ$61.56 Billion
As of April 2025 Argenx has a market cap of NZ$61.56 Billion. This makes Argenx the world's 549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Argenx from 2014 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$61.56 B | -7.29% |
| 2024 | NZ$66.40 B | 86.09% |
| 2023 | NZ$35.68 B | 8.1% |
| 2022 | NZ$33.01 B | 22.61% |
| 2021 | NZ$26.92 B | 38.55% |
| 2020 | NZ$19.43 B | 90.27% |
| 2019 | NZ$10.21 B | 95.39% |
| 2018 | NZ$5.22 B | 85.16% |
| 2017 | NZ$2.82 B | |
| 2014 | NZ$0.18 B |
End of Day market cap according to different sources
On Apr 24th, 2025 the market cap of Argenx was reported to be:
